Ralph F Levy

Title: Innovative Contributions of Ralph F. Levy in Oral Cyclosporin Formulations

Introduction

Ralph F. Levy, an accomplished inventor based in Pleasanton, California, has made significant contributions to the field of pharmaceutical formulations. With one patent to his name, Levy's work focuses on improving oral cyclosporin formulations, addressing an important need in immunosuppressive therapy.

Latest Patents

Levy’s notable patent, titled "Oral Cyclosporin Formulations," presents improved oral cyclosporin formulations that boast high bioavailability and can be effectively administered in hard capsules. The innovative formulations utilize cyclosporin delivered in an orally acceptable vehicle that includes at least one alkanol containing 2 to 3 carbon atoms, combined with a non-ionic surfactant and an ester of an alcohol and a fatty acid with a hydrocarbon chain of 14 to 18 carbon atoms. This development enhances the therapeutic efficacy of cyclosporin, which is crucial for patients requiring immunosuppressive treatment.

Career Highlights

Levy is associated with Sangstat Medical Corporation, a reputable organization known for its focus on immunosuppressive therapies. His expertise and innovative approach have greatly contributed to the company’s success in developing effective medical solutions.

Collaborations

Throughout his career, Levy has collaborated with talented professionals including Moo J. Cho and Philippe J. Pouletty. These collaborations have fostered a creative environment that has led to significant advancements in pharmaceutical formulations and therapeutic applications.

Conclusion

Ralph F. Levy's work on oral cyclosporin formulations exemplifies the intersection of innovation and medicine. With his patent contributions, he continues to impact the field of immunotherapy positively. His endeavors at Sangstat Medical Corporation, along with his collaborations, showcase the importance of teamwork in driving advancements in healthcare.